Blackrock Biotechnology ETF | IBB

Medium RiskEquity
Blackrock Biotechnology ETF
Issued by:iShares by Blackrock
Index : NASDAQ
Unit Price (NAV) :
Minimum investment: 1 unit
Blackrock Biotechnology ETF | IBB

Blackrock Biotechnology ETF | IBB


iShares Nasdaq Biotechnology ETF offers exposure to the biotech sub-sector of the health care industry, serving up access to a group of stocks that can thrive on technological breakthroughs and increased investment in medical processes.
IBB is primarily focused on U.S. stocks, though a smattering of international firms adds some degree of international diversification. This biotech ETF casts a considerably wider net than the other ETF options for exposure to the space, investing in more than 100 stocks. That feature can be particularly important in the biotech space, where company-specific developments can send a single stock soaring. IBB is somewhat top-heavy, but generally spreads exposure across large caps, mid caps, and small cap stocks.
This ETF is ideal for investors seeking long term growth by investing in disruptive biotech companies.

About the Fund Manager:
Founded in 1988, Blackrock is the largest asset manager in the world managing $6.28T. BlackRock operates globally with 70 offices in 30 countries and clients in 100 countries. Due to its power and the sheer size and scope of its financial assets and activities, BlackRock has been called the world's largest shadow bank..

Recommended for:


IBB Charts
52 Week High: $|52 Week Low: $
Blackrock Biotechnology ETF-1.30%32.64%14.19%10.32%16.15%

Asset Class

Asset type breakdown
Stock US90.62%
Stock non-US9.27%

IBB Holdings - Top 10

NameiWeightage (%)
Amgen Inc9.23%
Gilead Sciences, Inc6.93%
Illumina, Inc5%
Vertex Pharmaceuticals Incorporated4.64%
Moderna, Inc4.54%
Regeneron Pharmaceuticals, Inc4.25%
Biogen Inc3.43%
Alexion Pharmaceuticals, Inc2.88%
Seagen Inc2.22%
AstraZeneca PLC1.93%

IBB Sectors/Industry Breakdown

Sectori% of market value

IBB Countries

Countryi% of market value
North America91.05%
Europe Developed3.56%
Asia Emerging3.04%
United Kingdom2.05%
Africa/Middle East0.15%
Asia Developed0.15%

Projected Returns

Investment ofper month
gives returns of :
at 13.31% / annum
$in 10 years
for a time period of
Returnsbased on historic SIP returns of 13.31% per annum
$+ 13.31

IBB Summary Data

Total Net Assets $i
Average Mkt Cap Mil $i
Symbol IBB
Exchange XNAS
ISIN US4642875565
Cat. Benchmark MSCI ACWI NR USD
Asset class Equity
Category Health
Country US

IBB Portfolio Data & Volatility Analysis

Net Expense Ratio 0.46i
Beta 0.91i
Valuations Rates Portfolio PE 12.61142i
3 Year Standard Deviation 22.99i

Fund Strategy

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

IBB Fact Sheets & Reports

About iShares by Blackrock

"iShares" is a gathering of ETFs managed by Blackrock. Blackrock is an American investment management corporation founded in 1988. Some iShares ETFs are actively managed but most funds track a bond or share market index.

Blackrock Biotechnology ETF | IBB